By Mike Cherney ( May 11, 2010, 7:19 PM EDT) -- Pfizer Inc. was hit Tuesday with another securities fraud class action over its anti-inflammatory drug Bextra, this time being accused of failing to tell investors it was illegally promoting off-label uses for Bextra and three other drugs and offering kickbacks to doctors to promote the medications....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.